Global Blood Glucose Monitoring Devices Market 2023-2027
Technavio has been monitoring the blood glucose monitoring devices market and is forecast to grow by USD 7488.81 mn during 2022-2027, accelerating at a CAGR of 8.88% during the forecast period. Our report on the blood glucose monitoring devices market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising global burden of diabetes, technological advances in blood glucose monitoring devices, and the availability of reimbursement for blood glucose monitoring devices.
Technavio's blood glucose monitoring devices market is segmented as below:
By End-user
- Hospitals
- Home care
- Diagnostic centers
By Product
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies smart watch-based apps as one of the prime reasons driving the blood glucose monitoring devices market growth during the next few years. Also, increasing adoption of home healthcare devices and increased adoption of bundled product marketing strategy will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the blood glucose monitoring devices market covers the following areas:
- Blood glucose monitoring devices market sizing
- Blood glucose monitoring devices market forecast
- Blood glucose monitoring devices market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood glucose monitoring devices market vendors that include Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Bigfoot Biomedical Inc., Dexcom Inc., DiaMonTech AG, F. Hoffmann La Roche Ltd., GlySens Inc., Health Arx Technologies Pvt. Ltd., Insulet Corp., Level2 Medical Services P.A., Levels Health Inc., Medtronic Plc, Medtrum Technologies Inc., Novo Nordisk AS, PKvitality S.A.S., Sanofi SA, Senseonics Holdings Inc., SFC Fluidics Inc., Teladoc Health Inc., and Ypsomed AG. Also, the blood glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.